ARWR — ARROWHEAD PHARMACEUTICALS IN
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 538 SEC-registered investment managers reported holding ARWR (ARROWHEAD PHARMACEUTICALS IN) in their latest 13F filings, with a combined reported value of $8.44B across 318.69M shares. That is -10.5% by share count (-31.92M shares) versus the previous quarter, while reported value moved +20.9%. Ownership is concentrated: the five largest holders account for 41.1% of reported value and the top ten for 55.0%.
Compared with the prior quarter, 131 opened new positions, 164 added to existing stakes, 162 trimmed, 68 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of ARROWHEAD PHARMACEUTICALS IN (ARWR) include Vanguard Group, BlackRock Inc, Avoro Capital Advisors LLC, ranked by reported 13F value among the 797 institutional holders on this page.
ARWR is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Legendary Investors Holding ARWR
The superinvestors we track who report ARWR in their latest 13F filing — each shown at that manager’s own most recent quarter.
| Investor | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
|
|
Q2 2026 | 9.15M | $10.95M | 0.16% | Reduce |
Which stocks do these investors own together? → · Embed this widget →
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 388 | 141.07M | $3.65B | -5.0% |
| Q2 2026 | 538 | 318.69M | $8.44B | -9.7% |
| Q1 2026 | 472 | 334.89M | $6.29B | +62.1% |
| Q4 2025 | 411 | 116.89M | $7.70B | -1.1% |
| Q3 2025 | 312 | 113.46M | $3.91B | +4.5% |
| Q2 2025 | 287 | 104.99M | $1.66B | -1.4% |
| Q1 2025 | 265 | 105.02M | $1.34B | +6.8% |
| Q4 2024 | 268 | 97.90M | $1.84B | +0.6% |
Over the 8 quarters shown, institutional share counts increased 44% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q1 2026 (+62.1%).
Top Institutional Holders (Q3 2026) — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 15.14M | $990.97M | 0.02% | Add | |
| 6.21M | $406.51M | 0.02% | Reduce | |
| 6.12M | $400.47M | 0.01% | Hold | |
| 3.46M | $234.50M | 0.01% | Reduce | |
| 2.29M | $149.91M | 3.56% | Add | |
| 1.84M | $120.11M | 0.01% | Reduce | |
| 1.07M | $70.01M | 0.01% | Reduce | |
| 902.21K | $59.05M | 0.01% | Add | |
| 893.70K | $58.49M | 0.02% | Reduce | |
| 825.46K | $54.03M | 0.01% | Reduce | |
| 820.24K | $53.68M | 17.87% | Hold | |
| 797.48K | $52.20M | 0.02% | Add | |
| 767.19K | $50.21M | 0.05% | Add | |
| 441.33K | $28.88M | 0.02% | Reduce | |
| 437.21K | $28.62M | 0.05% | Reduce | |
| 27.19M | $27.84M | 1.16% | Add | |
| 425.00K | $27.82M | 1.29% | Add | |
| 413.10K | $27.04M | 0.04% | Add | |
| 391.82K | $25.65M | 0.01% | Add | |
| 376.46K | $24.64M | 0.02% | Hold | |
| 367.31K | $24.04M | 0.01% | Reduce | |
| 363.58K | $22.41M | 0.01% | Reduce | |
| 335.02K | $21.93M | 0.01% | Add | |
| 316.20K | $20.70M | 0.01% | Reduce | |
| 306.49K | $20.06M | 0.03% | Hold |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
Q1 2026 — 25 funds
Q4 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 21.32M | $1.42B | 0.04% | Add | |
| 15.29M | $1.02B | 0.01% | Reduce | |
| 10.62M | $705.39M | 7.76% | Reduce | |
| 6.52M | $432.89M | 0.02% | Add | |
| 6.40M | $425.15M | 0.01% | Hold | |
| 3.26M | $216.80M | 0.01% | Add | |
| 2.52M | $167.54M | 2.26% | Reduce | |
| 2.18M | $144.44M | 0.89% | Add | |
| 2.09M | $138.62M | 0.08% | Hold | |
| 1.83M | $121.69M | 0.48% | Add | |
| 1.83M | $121.69M | 1.72% | Add | |
| 1.77M | $117.47M | 0.80% | Reduce | |
| 1.70M | $113.16M | 0.01% | Reduce | |
| 1.50M | $99.62M | 2.97% | Reduce | |
| 1.48M | $97.99M | 0.01% | Reduce | |
| 1.35M | $89.87M | 0.01% | Add | |
| 1.35M | $89.87M | 0.01% | Add | |
| 1.35M | $89.38M | 0.01% | Add | |
| 1.31M | $87.09M | 0.03% | Add | |
| 1.28M | $85.00M | 0.04% | Add | |
| 1.26M | $83.68M | 0.02% | Reduce | |
| 1.03M | $68.64M | 0.07% | Add | |
| 987.29K | $65.55M | 0.04% | Add | |
| 900.00K | $59.75M | 2.03% | New | |
| 887.85K | $58.94M | 0.01% | Add |
Q3 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 20.22M | $697.55M | 0.02% | Add | |
| 16.04M | $553.08M | 0.01% | Add | |
| 10.90M | $375.94M | 5.57% | Add | |
| 6.40M | $220.65M | 0.01% | Hold | |
| 5.76M | $198.66M | 0.01% | Add | |
| 4.98M | $171.83M | 2.66% | Reduce | |
| 3.13M | $108.01M | 0.01% | Add | |
| 2.67M | $92.08M | 3.60% | Hold | |
| 2.10M | $72.41M | 0.52% | New | |
| 2.08M | $71.80M | 0.04% | Add | |
| 2.03M | $70.05M | 0.01% | Add | |
| 1.76M | $60.68M | 0.01% | Reduce | |
| 1.70M | $58.73M | 0.00% | Hold | |
| 1.67M | $57.62M | 0.43% | Add | |
| 1.44M | $49.56M | 0.08% | Reduce | |
| 1.35M | $46.42M | 0.01% | Add | |
| 1.35M | $46.42M | 0.01% | Add | |
| 1.31M | $45.24M | 0.01% | Add | |
| 1.05M | $36.35M | 0.01% | Add | |
| 1.00M | $34.50M | 0.16% | Add | |
| 993.00K | $34.25M | 0.55% | New | |
| 973.57K | $33.53M | 0.01% | Add | |
| 918.18K | $31.67M | 0.02% | Reduce | |
| 820.24K | $28.29M | 12.31% | Hold | |
| 814.55K | $28.09M | 0.01% | Hold |
Q2 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 19.42M | $306.91M | 0.01% | Reduce | |
| 15.53M | $245.30M | 0.00% | Add | |
| 10.60M | $167.48M | 2.93% | Reduce | |
| 6.37M | $100.66M | 0.00% | Reduce | |
| 5.23M | $82.67M | 1.43% | Hold | |
| 5.17M | $81.69M | 0.01% | Add | |
| 2.98M | $47.07M | 0.00% | Add | |
| 2.68M | $42.41M | 0.01% | Reduce | |
| 2.67M | $42.18M | 2.18% | Hold | |
| 2.16M | $34.06M | 0.05% | Add | |
| 1.92M | $30.41M | 0.00% | Add | |
| 1.71M | $26.94M | 0.00% | Reduce | |
| 1.60M | $25.29M | 0.02% | Reduce | |
| 1.27M | $20.10M | 0.00% | Add | |
| 1.17M | $18.50M | 0.00% | Add | |
| 1.17M | $18.50M | 0.00% | Add | |
| 960.25K | $15.17M | 0.03% | Reduce | |
| 939.17K | $14.84M | 0.14% | New | |
| 822.34K | $12.99M | 0.01% | Reduce | |
| 820.24K | $12.96M | 6.95% | Hold | |
| 818.08K | $12.93M | 0.00% | Add | |
| 762.66K | $12.05M | 0.00% | Add | |
| 746.16K | $11.79M | 0.06% | Add | |
| 612.21K | $9.85M | 2.12% | Reduce | |
| 623.10K | $9.84M | 0.01% | Reduce |
New Positions (Q2 2026)
- GEODE CAPITAL MANAGEMENT, LLC 3.53M sh · $298.81M
- Jupiter Topco LLC 1.22M sh · $99.62M
- Holocene Advisors, LP 1.11M sh · $90.16M
- Sixth Street Partners Management Company, L.P. 923.93K sh · $75.31M
- 1832 Asset Management L.P. 538.50K sh · $43.89M
- Artisan Partners Limited Partnership 310.71K sh · $25.33M
- DeepCurrents Investment Group LLC 19.00M sh · $22.81M
- Squarepoint Ops LLC 255.91K sh · $20.86M
- Life Cycle Investment Partners Ltd 209.07K sh · $17.04M
- BFC Planning, Inc. 149.69K sh · $12.20M
- Lombard Odier Asset Management (Europe) Ltd 8.45M sh · $10.15M
- Catalyst Funds Management Pty Ltd 117.60K sh · $9.59M
Fully Exited (vs previous quarter)
- Janus Henderson Group sold 1.44M sh · $90.12M
- RTW INVESTMENTS, LP sold 585.68K sh · $36.72M
- CPP Investments sold 325.70K sh · $20.42M
- STATE STREET CORP sold 13.70M sh · $14.19M
- Longaeva Partners L.P. sold 194.59K sh · $12.20M
- Polar Asset Management Partners Inc. sold 10.00M sh · $10.37M
- SCHRODER INVESTMENT MANAGEMENT GROUP sold 162.00K sh · $9.34M
- EVERETT HARRIS & CO /CA/ sold 104.91K sh · $6.58M
- Bridgewater Associates sold 95.55K sh · $5.99M
- Aquatic Capital Management LLC sold 80.23K sh · $5.03M
- PDT Partners, LLC sold 70.05K sh · $4.39M
- Quadrature Capital Ltd sold 55.55K sh · $3.48M
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BlackRock Inc | 15.14M | 14.83M | 18.16M | 21.32M | 20.22M | 19.42M | 19.93M | 16.18M | 15.84M | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 6.21M | 6.35M | 7.15M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 6.12M | 6.11M | 6.03M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | 3.46M | 3.53M | 4.28M | 3.26M | 3.13M | 2.98M | 2.95M | 2.95M | 2.96M | 2.94M | 2.75M | 2.33M | 2.22M | 2.15M | 2.08M | 1.97M | 1.89M | 1.85M | 1.85M | 1.82M |
| Siren, L.L.C. | 2.29M | 1.72M | 1.62M | 1.50M | 2.67M | 2.67M | 2.67M | 2.90M | 2.46M | — | — | — | — | — | — | — | — | — | — | — |
| Morgan Stanley | 1.84M | 3.80M | 695.00K | 1.48M | 1.70M | 1.71M | 1.85M | 1.54M | 1.61M | 1.82M | 1.14M | 899.45K | 735.43K | 541.61K | 634.27K | 431.19K | 427.39K | 538.97K | 304.04K | 327.87K |
| DIMENSIONAL FUND ADVISORS LP | 1.07M | 1.18M | 608.53K | 147.41K | 474.46K | 366.71K | — | 35.67K | 121.88K | 145.87K | 61.01K | 547.79K | 687.91K | — | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 902.21K | 896.74K | 965.77K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Fisher Asset Management, LLC | 893.70K | 957.69K | 1.11M | 1.31M | 1.05M | 451.65K | 483.25K | 142.94K | 122.26K | 11.74K | — | — | — | — | — | — | — | — | — | — |
| BNY Mellon | 825.46K | 859.54K | 960.14K | 887.85K | 814.55K | 818.08K | 776.04K | 830.06K | 866.40K | 1.09M | 1.05M | 957.91K | 990.63K | 1.04M | 1.04M | 1.07M | 1.07M | 1.04M | 1.04M | 1.04M |
| Western Financial Corp/CA | 820.24K | 820.24K | 820.24K | 820.24K | 820.24K | 820.24K | 820.24K | 820.24K | 820.24K | 820.24K | 820.24K | 820.24K | 820.24K | — | — | — | — | — | — | — |
| UBS Group AG | 797.48K | 152.00K | 4.20M | 987.29K | 918.18K | 1.60M | 1.63M | 1.31M | 441.51K | 348.30K | 450.92K | 508.59K | 369.60K | 330.97K | 299.34K | 307.71K | 103.55K | 91.22K | 159.33K | 155.02K |
| Pictet Asset Management Holding SA | 767.19K | 573.42K | 1.27M | 1.03M | 291.02K | 277.33K | 288.03K | 14.21K | 14.21K | 743.68K | 1.23M | 11.66K | 11.66K | — | — | — | — | — | — | — |
| FIRST TRUST ADVISORS LP | 441.33K | 1.35M | 149.15K | 237.73K | 207.96K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Connor, Clark & Lunn Investment Management Ltd. | 437.21K | 625.57K | 836.98K | 663.26K | 124.53K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| MACKAY SHIELDS LLC | 27.19M | 20.46M | 3.00M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Affinity Asset Advisors, LLC | 425.00K | 150.00K | 200.00K | 70.00K | — | — | — | 300.00K | 325.00K | 50.00K | 120.00K | — | — | — | — | — | — | — | — | — |
| Aberdeen Group plc | 413.10K | 251.97K | 363.97K | 286.15K | 520.64K | 960.25K | 1.07M | 450.07K | 401.15K | 248.67K | — | — | — | — | — | — | — | — | — | — |
| AMERICAN CENTURY COMPANIES INC | 391.82K | 364.21K | 651.54K | 7.74K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| RHUMBLINE ADVISERS | 376.46K | 374.90K | 404.44K | 352.39K | 371.11K | 360.00K | 345.98K | 380.34K | 372.43K | 383.03K | 372.11K | 322.37K | 340.87K | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold ARWR?
As of 2026-Q2, 538 institutional funds reported holding ARWR (ARROWHEAD PHARMACEUTICALS IN) in SEC 13F filings, with a combined reported value of $8.44B.
How many shares of ARWR do institutions own?
13F filers reported 318.69M shares of ARWR, worth $8.44B in aggregate at the end of 2026-Q2.
Is institutional ownership of ARWR rising or falling?
Share counts moved -10.5% versus the prior quarter — distribution.
Who are the top institutional holders of ARWR?
The largest 13F holders are Vanguard Group, BlackRock Inc, Avoro Capital Advisors LLC, VANGUARD PORTFOLIO MANAGEMENT LLC, VANGUARD CAPITAL MANAGEMENT LLC; the top 25 are ranked at the top of this page.
Who are the major shareholders of ARROWHEAD PHARMACEUTICALS IN?
The major shareholders of ARROWHEAD PHARMACEUTICALS IN (ARWR) by reported 13F value are Vanguard Group, BlackRock Inc, Avoro Capital Advisors LLC, VANGUARD PORTFOLIO MANAGEMENT LLC, VANGUARD CAPITAL MANAGEMENT LLC, among 797 institutional holders.
Which legendary investors own ARWR?
1 of the legendary investors tracked on HoldingsHub report ARWR (ARROWHEAD PHARMACEUTICALS IN) in their latest 13F filings, led by Howard Marks. Each is shown at that manager's own most recent quarter.
Do superinvestors agree on ARWR?
1 tracked superinvestors hold ARWR simultaneously — see the consensus page for the stocks they own together.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.